Comparison of functional protein transduction domains using the NEMO binding domain peptide

Pharmaceuticals

Volumn 3, Issue 1, 2010, Pages 110-124

  Khaja, Khaleel ^a   Robbins, Paul ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Delayed type hypesenDTH; NEMO binding domain; NF B; Protein transduction domains

Indexed keywords

ANTENNAPEDIA PROTEIN; ANTIINFLAMMATORY AGENT; ARGININE; BINDING PROTEIN; FIBROBLAST GROWTH FACTOR; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; KEYHOLE LIMPET HEMOCYANIN; LYSINE; NEMO BINDING DOMAIN PEPTIDE; PROTEIN TRANSDUCTION DOMAIN 5; SYNAPTOTAGMIN I; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION;

EID: 77951903201     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3010110     Document Type: Article

References (30)

1. Eguchi, A.; Akuta, T.; Okuyama, H.; Senda, T.; Yokoi, H.; Inokuchi, H.; Fujita, S.; Hayakawa, T.; Takeda, K.; Hasegawa, M.; Nakanishi, M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 2001, 276, 26204-26210.
2. Josephson, L.; Tung, C.H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 1999, 10, 186-191.
3. Lewin, M.; Carlesso, N.; Tung, C.H.; Tang, X.W.; Cory, D.; Scadden, D.T.; Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000, 18, 410-414.
4. Rothbard, J.B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P.L.; Wender, P.A.; Khavari, P.A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 2000, 6, 1253-1257.
5. Torchilin, V.P.; Rammohan, R.; Weissig, V.; Levchenko, T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 2001, 98, 8786-8791.
6. Wadia, J.S.; Dowdy, S.F. Protein transduction technology. Curr. Opin. Biotechnol. 2002, 13, 52-56.
7. Mai, J.C.; Mi, Z.; Kim, S.H.; Ng, B.; Robbins, P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 2001, 61, 7709-7712.
8. May, M.J.; D'Acquisto, F.; Madge, L.A.; Glockner, J.; Pober, J.S.; Ghosh, S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000, 289, 1550-1554.
9. Schwarze, S.R.; Ho, A.; Vocero-Akbani, A.; Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285, 1569-1572.
10. Zhou, J.P.; Feng, Z.G.; Yuan, B.L.; Yu, S.Z.; Li, Q.; Qu, H.Y.; Sun, M.J. Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice. Brain Res. 2008, 1191, 12-19.
11. Cao, G.; Pei, W.; Ge, H.; Liang, Q.; Luo, Y.; Sharp, F.R.; Lu, A.; Ran, R.; Graham, S.H.; Chen, J. In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J. Neurosci. 2002, 22, 5423-5431.
12. Mai, J.C.; Shen, H.; Watkins, S.C.; Cheng, T.; Robbins, P.D. Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J. Biol. Chem. 2002, 277, 30208-30218.
13. Benito, M.J.; Murphy, E.; Murphy, E.P.; van den Berg, W.B.; FitzGerald, O.; Bresnihan, B. Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum. 2004, 50, 1781-1787.
14. Handel, M.L.; McMorrow, L.B.; Gravallese, E.M. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p 65. Arthritis Rheum. 1995, 38, 1762-1770.
15. Jun, H.S.; Yoon, C.S.; Zbytnuik, L.; van Rooijen, N.; Yoon, J.W. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1999, 189, 347-358.
16. Oyama, T.; Ran, S.; Ishida, T.; Nadaf, S.; Kerr, L.; Carbone, D.P.; Gabrilovich, D.I. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor- kappa B activation in hemopoietic progenitor cells. J. Immunol. 1998, 160, 1224-1232.
17. Poligone, B.; Weaver, D.J., Jr.; Sen, P.; Baldwin, A.S., Jr.; Tisch, R. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 2002, 168, 188-196.
18. Weaver, D.J., Jr.; Poligone, B.; Bui, T.; Abdel-Motal, U.M.; Baldwin, A.S., Jr.; Tisch, R. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. J. Immunol. 2001, 167, 1461-1468.
19. Wheat, W.; Kupfer, R.; Gutches, D.G.; Rayat, G.R.; Beilke, J.; Scheinman, R.I.; Wegmann, D.R. Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur. J. Immunol. 2004, 34, 1395-1404.
20. DiDonato, J.A.; Hayakawa, M.; Rothwarf, D.M.; Zandi, E.; Karin, M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997, 388, 548-554.
21. Rehman, K.K.; Bertera, S.; Bottino, R.; Balamurugan, A.N.; Mai, J.C.; Mi, Z.; Trucco, M.; Robbins, P.D. Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem. 2003, 278, 9862-9868.
22. Giannoukakis, N.; Rudert, W.A.; Trucco, M.; Robbins, P.D. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J. Biol. Chem. 2000, 275, 36509-36513.
23. Zandi, E.; Chen, Y.; Karin, M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 1998, 281, 1360-1363.
24. Sugita, T.; Yoshikawa, T.; Mukai, Y.; Yamanada, N.; Imai, S.; Nagano, K.; Yoshida, Y.; Shibata, H.; Yoshioka, Y.; Nakagawa, S.; Kamada, H.; Tsunoda, S.I.; Tsutsumi, Y. Comparative study on transduction and toxicity of protein transduction domains. Br. J. Pharmacol. 2008, 153, 1143-1152.
25. Jimi, E.; Aoki, K.; Saito, H.; D'Acquisto, F.; May, M.J.; Nakamura, I.; Sudo, T.; Kojima, T.; Okamoto, F.; Fukushima, H.; Okabe, K.; Ohya, K.; Ghosh, S. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 2004, 10, 617-624.
26. Tas, S.W.; Vervoordeldonk, M.J.; Hajji, N.; May, M.J.; Ghosh, S.; Tak, P.P. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res. Ther. 2006, 8, R86.
27. di Meglio, P.; Ianaro, A.; Ghosh, S. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 2005, 52, 951-958.
28. Dave, S.H.; Tilstra, J.S.; Matsuoka, K.; Li, F.; Karrasch, T.; Uno, J.K.; Sepulveda, A.R.; Jobin, C.; Baldwin, A.S.; Robbins, P.D.; Plevy, S.E. Amelioration of chronic murine colitis by peptidemediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J. Immunol. 2007, 179, 7852-7859.
29. Acharyya, S.; Villalta, S.A.; Bakkar, N.; Bupha-Intr, T.; Janssen, P.M.; Carathers, M.; Li, Z.W.; Beg, A.A.; Ghosh, S.; Sahenk, Z.; Weinstein, M.; Gardner, K.L.; Rafael-Fortney, J.A.; Karin, M.; Tidball, J.G.; Baldwin, A.S.; Guttridge, D.C. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest. 2007, 117, 889-901.
30. Bianco, N.R.; Kim, S.H.; Ruffner, M.A.; Robbins, P.D. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum. 2009, 60, 380-389.